This novel CD4-IL15/IL15sushi CAR then demonstrated potent in vitro and in vivo anti-tumor efficacy in multiple CD4+ cell lines, confirming that the addition of the IL15/IL15sushi complex enhanced anti-tumor targeting and killing. Here, IL15 is linked to neoplasm.